NewGenIvf (NIVF) EPS (Weighted Average and Diluted) (2024)
NewGenIvf (NIVF) reported EPS (Weighted Average and Diluted) of -$4560.4 for Q4 2024.
NewGenIvf (NIVF) EPS (Weighted Average and Diluted) (2024) Analysis & Trends
NewGenIvf (NIVF) has 1 years of EPS (Weighted Average and Diluted) data on file, last reported at -$4560.4 in Q4 2024.
- EPS (Weighted Average and Diluted) for Q4 2024 came in at -$4560.4, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$4560.4 (changed N/A YoY), and the FY2025 annual result was $3.04, up 100.07% from the prior year.
- EPS (Weighted Average and Diluted) was little changed at -$4560.4 in Q4 2024 per NIVF's latest filing.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$4560.4 in Q4 2024 and troughed at -$4560.4 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 7.15 |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 8.01 |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 2.87 |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 1.93 |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 1.67 |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 5.65 |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | - |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 4.84 |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 0.50 |
| 10 | NewGenIvf | - | - | 524,025.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4,560.37 |